PPT-EXCITE ISR Freedom from target lesion revascularization (TLR) at 6

months 735 of the laser group vs 518 of the angioplasty alone group p lt 0005 Freedom from major adverse events 30 days 942 of the laser group vs 792 of the angioplasty alone group p lt 0001. Laura . Mauri MD, . MSc. on . behalf of the . RESOLUTE US Investigators. Brigham and Women’s Hospital. Boston, . MA. ACC 2012. Enrollment Complete - In Follow Up. RESOLUTE. 1. Non-RCT First-in-Human (R=139). and how to apply, please visit: . e. xcite.marsdd.com. Ontario’s Evidence Revolution . Commitment to Evidence in Healthcare . Ontario Excellent Care for All Act (2010). The people of Ontario and their Government: . by. Mariah . Germosen. What comes to your mind when you think about the word EXCITE?. The real meaning of EXCITE. verb. . Definition. : . inspire. ; upset. . Synonyms: accelerate. , agitate. ,. . Excel, Create & Inspire the Teaching Experience . July 13-17, 2009. September 8, 2009. PCC Report. Research. Penn State – Summer College Opportunity Program (SCOPE). (4 week program currently offered) (10. BioN. IR. . Ridaforolimus. Eluting Coronary Stent System . I. n . C. oronary . S. tenosis Trial. David E. Kandzari, MD . on behalf of the . BIONICS investigators. Disclosure. Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. e. valuation of routine follow-up coronary. A. ngiography after percutaneous . C. oronary intervention . T. rial (. ReACT. ). Hiroki Shiomi, MD. Kyoto University Graduate School of Medicine. bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. . Engage. . Excite. Candace Wheeler. Vice President. Strategic Communications &. . Marketing. Uniting to Protect EARNED Benefits. . Educate. . Engage. . Excite. &. Over 2 Million . saveourbenefit.org. Educate Engage Excite. Mr. Patrick B. Nixon. President. Promote, Protect and Enhance. . the Military Resale and Quality of Life Benefits. on Behalf of Our Members and the Military Community!. vs. FFR-guided . Coronary Intervention . –. . iFR. -SWEDEHEART. Matthias Götberg, . MD, . PhD. Department of Cardiology, Lund University. Skane. University Hospital. Lund, Sweden. Disclosures. Volcano/Philips: Unrestricted grant to fund . Devices . & Techniques. Jihad A. Mustapha, MD, FSCAI, FACC. Advanced Cardiac & Vascular Centers for Amputation Prevention. Grand Rapids, MI. Disclosures. Bard Peripheral Vascular – Consultant. RECIST 1.1. Criteria Handout. Basic Paradigm. Assess at baseline. Look for measurable lesions. Select target and non-target lesions. Measure target lesions. Follow-up evaluation. Measure target lesions. iFR-Swedeheart. 5-year outcome. Matthias Götberg, MD, PhD. Skane. University Hospital, Lund University, Sweden. - on behalf of the . iFR-Swedeheart. investigators. Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below.. on behalf of the OPTIMUM Investigators. O. utcomes of . P. ercutaneous . Revasculariza. TI. on. for . M. anagement of . S. U. rgically. Ineligible Patients with . M. ultivessel or Left Main Coronary Artery Disease: Primary Results from the .